Free Trial

Belite Bio (BLTE) Short Interest Ratio & Short Volume

+0.49 (+1.02%)
(As of 07/18/2024 ET)

Belite Bio Short Interest Data

Current Short Interest
Previous Short Interest
Change Vs. Previous Month
Dollar Volume Sold Short
$10.16 million
Short Interest Ratio
4.2 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
Percentage of Shares Shorted
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Belite Bio ?

Sign up to receive the latest short interest report for Belite Bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BLTE Short Interest Over Time

BLTE Days to Cover Over Time

BLTE Percentage of Float Shorted Over Time

Belite Bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2024222,500 shares $10.16 million +516.3%N/A4.2 $45.68
6/15/202436,100 shares $1.80 million -22.9%N/A0.7 $49.96
5/31/202446,800 shares $2.29 million +32.2%N/A1.1 $48.95
5/15/202435,400 shares $1.50 million +87.3%N/A0.9 $42.45
4/30/202418,900 shares $767,340.00 -44.4%N/A0.5 $40.60
4/15/202434,000 shares $1.24 million -13.0%N/A0.7 $36.40
3/31/202439,100 shares $1.50 million -34.3%N/A0.6 $38.37
3/15/202459,500 shares $2.29 million +20.7%N/A0.8 $38.47
2/29/202449,300 shares $2.28 million +4.5%N/A0.6 $46.25
2/15/202447,200 shares $2.27 million -11.3%N/A0.5 $48.00
1/31/202453,200 shares $2.31 million -6.0%N/A0.5 $43.43
1/15/202456,600 shares $2.59 million +40.8%N/A0.4 $45.81
12/31/202340,200 shares $1.84 million -47.9%N/A0.3 $45.75
12/15/202377,100 shares $3.46 million +19.5%N/A0.6 $44.83
11/30/202364,500 shares $2.71 million -26.3%N/A0.5 $42.07
11/15/202387,500 shares $3.24 million -9.7%N/A0.7 $37.02
10/31/202396,900 shares $3.63 million +172.2%N/A0.8 $37.51
10/15/202335,600 shares $1.14 million -5.3%N/A0.4 $32.00
9/30/202337,600 shares $1.20 million -14.9%N/A0.5 $31.85
9/15/202344,200 shares $1.42 million +17.9%N/A0.5 $32.20
8/31/202337,500 shares $1.29 million +7.1%N/A0.5 $34.35
8/15/202335,000 shares $775,950.00 -24.1%N/A0.5 $22.17
7/31/202346,100 shares $1.07 million +30.6%N/A0.8 $23.22
7/15/202335,300 shares $474,432.00 -26.6%N/A0.7 $13.44
6/30/202348,100 shares $678,691.00 +13.7%N/A1.4 $14.11
6/15/202342,300 shares $607,005.00 +60.8%N/A1.4 $14.35
5/31/202326,300 shares $433,687.00 -3.3%N/A1 $16.49
5/15/202327,200 shares $639,200.00 -18.6%N/A2.3 $23.50
4/30/202333,400 shares $966,262.00 +5.4%N/A3.1 $28.93
4/15/202331,700 shares $911,375.00 +13.6%N/A3 $28.75
3/31/202327,900 shares $834,207.21 -24.4%N/A2.7 $29.90
3/15/202336,900 shares $1.13 million -4.9%N/A3.2 $30.50
2/28/202338,800 shares $1.28 million +1.8%N/A3.6 $33.10
2/15/202338,100 shares $1.22 million -8.9%N/A3 $32.00
1/31/202341,800 shares $1.25 million -52.8%N/A3.2 $29.89
1/15/202388,600 shares $2.53 million -12.1%N/A4.9 $28.50
12/30/2022100,800 shares $3.04 million -1.4%N/A4.8 $30.15
12/15/2022102,200 shares $3.04 million -13.2%N/A3.9 $29.73
11/30/2022117,800 shares $3.86 million -8.8%N/A4.1 $32.77
11/15/2022129,200 shares $3.24 million -5.3%N/A3.9 $25.10
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide
10/31/2022136,400 shares $3.97 million +5.1%N/A3.3 $29.07
10/15/2022129,800 shares $3.60 million +3.8%N/A2.9 $27.77
9/30/2022125,100 shares $4.20 million -11.3%N/A2.1 $33.55
9/15/2022141,100 shares $5.02 million -5.5%N/A2 $35.55
8/31/2022149,300 shares $4.79 million +30.1%N/A1.7 $32.11
8/15/2022114,800 shares $3.50 million +14.1%N/A1.4 $30.50
7/31/2022100,600 shares $3.38 million -9.2%N/A1 $33.60
7/15/2022110,800 shares $4.66 million No ChangeN/A0.3 $42.07

BLTE Short Interest - Frequently Asked Questions

What is Belite Bio's current short interest?

Short interest is the volume of Belite Bio shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 222,500 shares of BLTE short. Learn More on Belite Bio's current short interest.

What is a good short interest ratio for Belite Bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLTE shares currently have a short interest ratio of 4.0. Learn More on Belite Bio's short interest ratio.

Is Belite Bio's short interest increasing or decreasing?

Belite Bio saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 222,500 shares, an increase of 516.3% from the previous total of 36,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Belite Bio's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Belite Bio: BridgeBio Pharma, Inc. (14.21%), Nuvalent, Inc. (21.62%), Organon & Co. (3.10%), Apellis Pharmaceuticals, Inc. (12.20%), Avidity Biosciences, Inc. (11.32%), Crinetics Pharmaceuticals, Inc. (7.44%), Alkermes plc (8.08%), Axsome Therapeutics, Inc. (18.06%), Dyne Therapeutics, Inc. (10.39%), Ultragenyx Pharmaceutical Inc. (5.10%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Belite Bio stock?

Short selling BLTE is an investing strategy that aims to generate trading profit from Belite Bio as its price is falling. BLTE shares are trading up $0.49 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Belite Bio?

A short squeeze for Belite Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLTE, which in turn drives the price of the stock up even further.

How often is Belite Bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLTE, twice per month. The most recent reporting period available is June, 30 2024.

This page (NASDAQ:BLTE) was last updated on 7/18/2024 by Staff

From Our Partners